Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 17410435)

Published in Dig Dis Sci on April 05, 2007

Authors

Giuseppe Comparato1, Libera Fanigliulo, Lucas G Cavallaro, Giovanni Aragona, Giulia Martina Cavestro, Veronica Iori, Marta Maino, Giancarlo Mazzocchi, Pierantonio Muzzetto, Giancarlo Colla, Mario Sianesi, Angelo Franzé, Francesco Di Mario

Author Affiliations

1: Department of Clinical Sciences, Chair of Gastroenterology, University of Parma, Parma, Italy.

Articles citing this

Review of current classifications for diverticular disease and a translation into clinical practice. Int J Colorectal Dis (2011) 1.14

Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration. Int J Colorectal Dis (2013) 1.10

Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterol J (2014) 0.97

Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines. Tech Coloproctol (2015) 0.92

New and emerging treatments for the prevention of recurrent diverticulitis. Clin Exp Gastroenterol (2011) 0.87

Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies. Therap Adv Gastroenterol (2011) 0.86

Diverticular disease: A therapeutic overview. World J Gastrointest Pharmacol Ther (2010) 0.83

Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis. Ann Gastroenterol (2016) 0.79

Management of diverticular disease. Nat Rev Gastroenterol Hepatol (2015) 0.78

Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease. Dig Dis Sci (2011) 0.77

Absence of mucosal inflammation in uncomplicated diverticular disease. Dig Dis Sci (2011) 0.77

Colonic diverticular disease. BMJ Clin Evid (2011) 0.77

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence. Aliment Pharmacol Ther (2017) 0.76

Systematic review of medical therapy to prevent recurrent diverticulitis. Int J Colorectal Dis (2012) 0.76

Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials. Drug Des Devel Ther (2014) 0.75

Effect of oral mesalamine on inflammatory response in acute uncomplicated diverticulitis. World J Gastroenterol (2015) 0.75

Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon. Dig Dis Sci (2015) 0.75

Articles cited by this

Diverticular disease of the colon. Lancet (2004) 4.03

Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1999) 2.79

Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol (1975) 2.53

Medical progress. Diverticular disease of the colon. N Engl J Med (1980) 2.26

Inflammatory bowel disease. N Engl J Med (1996) 2.22

Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc (1999) 2.21

Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet (1977) 2.16

Oxidants and free radicals in inflammatory bowel disease. Lancet (1994) 1.90

A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet (1976) 1.58

A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr (1998) 1.54

Diverticular disease-associated chronic colitis. Am J Surg Pathol (1996) 1.50

Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis (2002) 1.12

Pathogenesis of colonic diverticula. Br J Surg (2002) 1.10

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther (1995) 1.09

Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci (2005) 1.02

Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance. Int J Colorectal Dis (1992) 1.01

Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol (1992) 0.98

The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol (2003) 0.97

[Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results]. Minerva Gastroenterol Dietol (1999) 0.94

Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis (2002) 0.93

Endoscopic findings of diverticular inflammation in colonoscopy patients without clinical acute diverticulitis: prevalence and endoscopic spectrum. Am J Gastroenterol (2003) 0.92

The overlap of inflammatory bowel disease and diverticular disease. J Clin Gastroenterol (2004) 0.91

Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades. Gut (1996) 0.86

Pathophysiological aspects of diverticular disease of colon and role of large bowel motility. World J Gastroenterol (2003) 0.84

Type I and III collagens in human colon cancer and diverticulosis. Scand J Gastroenterol (2000) 0.84

Influence on symptoms and transit-time of Vi-SiblinR in diverticular disease. Acta Chir Scand Suppl (1980) 0.82

Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: a synergistic interaction? Free Radic Res (1998) 0.81

Mesalazine for diverticular disease of the colon--a new role for an old drug. Expert Opin Pharmacother (2005) 0.78

Diverticular disease of the colon. Lancet (2004) 0.75

Articles by these authors

High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study. Am J Gastroenterol (2008) 3.31

A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet (2006) 1.90

Connections between genetics and clinical data: Role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis. Am J Gastroenterol (2009) 1.63

The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count. J Surg Oncol (2006) 1.60

Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clin Gastroenterol Hepatol (2010) 1.58

Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. Future Oncol (2013) 1.46

Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol (2003) 1.45

Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease. Intern Emerg Med (2011) 1.42

Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40

Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: a multicenter study. Am J Gastroenterol (2008) 1.34

Small bowel capsule endoscopy in clinical practice: a multicenter 7-year survey. Eur J Gastroenterol Hepatol (2010) 1.13

Imaging of a small bowel cavernous hemangioma: report of a case with emphasis on the use of computed tomography and enteroclysis. Acta Biomed (2007) 1.13

Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis (2010) 1.02

Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci (2005) 1.02

Predicting mortality in non-variceal upper gastrointestinal bleeders: validation of the Italian PNED Score and Prospective Comparison with the Rockall Score. Am J Gastroenterol (2010) 1.02

A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter (2007) 1.01

'Rescue' therapies for the management of Helicobacter pylori infection. Dig Dis (2006) 0.97

Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis (2007) 0.97

The utility of serum PTH assessment 24 hours after total thyroidectomy. Otolaryngol Head Neck Surg (2005) 0.96

Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study. Clin Nucl Med (2010) 0.95

A Case of Severe Sprue-like Enteropathy Associated With Losartan. J Clin Gastroenterol (2015) 0.95

Spontaneous renal allograft rupture without acute rejection. Acta Biomed (2004) 0.95

Progressive familial intrahepatic cholestasis. Acta Biomed (2002) 0.93

Endoscopic treatment of esophageal and colo-rectal fistulas with fibrin glue. Acta Biomed (2005) 0.92

The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma. BMC Cancer (2007) 0.91

Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci (2006) 0.89

Pancreatic pseudocysts following acute pancreatitis: risk factors influencing therapeutic outcomes. JOP (2004) 0.87

Minimally invasive video-assisted thyroidectomy (MIVAT): what is the real advantage? Langenbecks Arch Surg (2010) 0.87

Gastric metastasis from breast carcinoma. Report of three cases, diagnostic-therapeutic critical close examination and literature review. Ann Ital Chir (2010) 0.86

Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Digestion (2004) 0.85

Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey. World J Gastroenterol (2006) 0.85

Cefepime for prophylaxis of infections in the surgery of cholelithiasis. Results of a multicentric comparative trial. Acta Biomed (2008) 0.83

Minimally invasive video-assisted thyroidectomy in differentiated thyroid cancer: a 1-year follow-up. Surg Laparosc Endosc Percutan Tech (2009) 0.82

Association between primary hyperparathyroidism and thyroid disease. Role of preoperative PTH. Ann Ital Chir (2010) 0.82

Role of gut microflora and probiotic effects in the irritable bowel syndrome. Acta Biomed (2006) 0.82

Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Dig Dis (2007) 0.81

Imaging for oncologic staging and follow-up: review of current methods and novel approaches. Acta Biomed (2008) 0.81

Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey. Dig Dis Sci (2005) 0.81

Preliminary experience in minimally invasive videoassisted thyroidectomy (MIVAT). Acta Biomed (2006) 0.80

A comparison of minimally invasive video-assisted parathyroidectomy and traditional parathyroidectomy for parathyroid adenoma. J Cancer (2013) 0.80

Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World J Gastroenterol (2012) 0.79

A rare case of thyroid haemangiosarcoma. Chir Ital (2007) 0.79

Pelvic pain and papillary thyroid carcinoma: case report. Ann Ital Chir (2013) 0.78

Macrohematuria caused by a fall in prothrombin activity as a clinical presentation of celiac disease. J Clin Gastroenterol (2002) 0.78

Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent. Oncol Rep (2004) 0.78

Choledocholithiasis and endo-laparoscopic rendezvous. Analysis of 59 consecutive cases. Ann Ital Chir (2011) 0.78

[Rupture of the spleen in angiosarcoma: a case report and review of the literature]. Chir Ital (2005) 0.78

Are we changing our inclusion criteria for the minimally invasive videoassisted thyroidectomy? Ann Ital Chir (2014) 0.78

Can we improve the detection rate and interobserver agreement in capsule endoscopy? Dig Liver Dis (2012) 0.78

Minimally invasive video-assisted thyroidectomy for papillary thyroid cancer: a prospective 5-year follow-up study. Tumori (2015) 0.78

Pancreas procurement technique. Lessons learned from an initial experience. Acta Biomed (2006) 0.78

Radiologic assessment of rectosigmoid cancer before and after neoadjuvant radiation therapy: comparison between quantitation techniques. AJR Am J Roentgenol (2005) 0.78

Choledocholithiasis caused by migration of a surgical clip after video laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A (2003) 0.78

Renal hemodynamic control by endothelin and nitric oxide under angiotensin II blockade in man. Hypertension (2002) 0.78

Unintentional parathyroidectomy and postoperative hypocalcaemia. Conventional thyroidectomy versus miniinvasive thyroidectomy. Ann Ital Chir (2015) 0.77

Is it possible to identify a risk factor condition of hypocalcemia in patients candidates to thyroidectomy for benign disease? Ann Ital Chir (2011) 0.77

Use of mesalazine in diverticular disease. J Clin Gastroenterol (2006) 0.77

Is CD10 a reliable marker of invasive colorectal cancer? Ann Ital Chir (2011) 0.77

A translocation t(4; 13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma. Tumori (2007) 0.77

[Gastric polyps: a clinical contribution]. Chir Ital (2002) 0.77

Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Fundam Clin Pharmacol (2005) 0.77

The race from chronic pancreatitis to pancreatic cancer. JOP (2003) 0.77

Thyroidectomy for differentiated carcinoma in older patients on a short stay basis. Acta Biomed (2009) 0.77